TIMI risk score underestimates prognosis in unstable angina/non‐ST segment elevation myocardial infarction

References

• Antman E. M., Cohen M., Bernink P. J., McCabe C. H., Horacek T., Papuchis G., et al. The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–42
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Murphy S. A., Assmann S. F., Giugliano R. P., Cannon C. P., et al. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies. Eur Heart J 2004; 25: 1139–45
   Google Scholar
• Morrow D. A., Antman E. M., Snapinn S. M., McCabe C. H., Theroux P., Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non‐ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM‐PLUS. Eur Heart J 2002; 23: 223–9
   PubMed Web of Science ®Google Scholar
• Antman E. M., McCabe C. H., Gurfinkel E. P., Turpie A. G., Bernink P. J., Salein D., et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non‐Q‐wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999; 100: 1593–601
   PubMed Web of Science ®Google Scholar
• Cohen M., Demers C., Gurfinkel E. P., Turpie A. G., Fromell G. J., Goodman S., et al. A comparison of low‐molecular‐weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non‐q‐wave coronary events study group. N Engl J Med 1997; 337: 447–52
   PubMed Web of Science ®Google Scholar
• Sabatine M. S., Antman E. M. The thrombolysis in myocardial infarction risk score in unstable angina/non‐ST‐segment elevation myocardial infarction. J Am Coll Cardiol 2003; 41((Suppl S))89S–95S
   Google Scholar
• Cannon C. P., Weintraub W. S., Demopoulos L. A., Vicari R., Frey M. J., Lakkis N., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879–87
   PubMed Web of Science ®Google Scholar
• Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non‐Q‐wave myocardial infarction. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM‐PLUS) study investigators. N Engl J Med 1998; 338: 1488–97
   PubMed Web of Science ®Google Scholar
• Myocardial infarction redefined–a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502–13
   PubMed Web of Science ®Google Scholar
• Braunwald E., Antman E. M., Beasley J. W., Califf R. M., Cheitlin M. D., Hochman J. S., et al. ACC/AHA guidelines for the management of patients with unstable angina and non‐ST‐segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193–209
   PubMed Web of Science ®Google Scholar
• Jaffe A. S., Ravkilde J., Roberts R., Naslund U., Apple F. S., Galvani M., et al. It's time for a change to a troponin standard. Circulation 2000; 102: 1216–20
   PubMed Web of Science ®Google Scholar
• Newby L. K., Storrow A. B., Gibler W. B., Garvey J. L., Tucker J. F., Kaplan A. L., et al. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase‐MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 2001; 103: 1832–7
   PubMed Web of Science ®Google Scholar
• Yan A. T., Yan R. T., Tan M., Chow C. M., Fitchett D., Stanton E., et al. Troponin is more useful than creatine kinase in predicting one‐year mortality among acute coronary syndrome patients. Eur Heart J 2004; 25: 2006–12
   Google Scholar
• Brennan M. L., Penn M. S., Van Lente F., Nambi V., Shishehbor M. H., Aviles R. J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349: 1595–604
   PubMed Web of Science ®Google Scholar
• de Araujo Goncalves P., Ferreira J., Aguiar C., Seabra‐Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS. Eur Heart J 2005; 26: 865–72
   PubMedGoogle Scholar
• Rahimi K., Watzlawek S., Thiele H., Secknus M. A., Hayerizadeh B. F., Niebauer J., et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non‐ST‐segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J 2006; 27: 1706–11
   Google Scholar